中国医药科学Issue(11)：69-70,107,3.
早期强化阿托伐他汀治疗不稳定型心绞痛患者45例临床观察
The observation of unstable angina with atorvastatin in early phase and intensive therapy:an analysis of 45 cases
郝建光1
作者信息
- 1. 沈阳市铁西区中心医院内科，辽宁沈阳110021
- 折叠
摘要
Abstract
Objective To explore the clinical efficacy of atorvastatin in large dose on unstable angina. Methods From February 2012 to February 2013, 85 cases of unstable angina of our hospital were randomly divided into two groups: The control group (40 cases) and treatment group (45 cases). Both group were treated with normal medicine, at the same time, the control group were given atorvastatin 10 mg/d, while the treatment group were given Atorvastatin 20mg/d. Compare the incidence of cardiovascular events, blood lipids and hs-CRP level before and after treatment. Results The hs-CRP level of the control group was significantly lower than the treatment group(P < 0.05) after 7days and 15days treatment. And the target rate of LDL-C and TC of the treatment group were all improved after 30days. Conclusion Early and large dose application of atorvastatin can significantly reduce the level of hs-CRP and blood lipid of patients with unstable angina, which contributes to the incidence of cardiovascular events and plays an improve role in improving patients' prognosis.关键词
不稳定型心绞痛/超敏C反应蛋白/阿托伐他汀Key words
Unstable angina/Hs-CRP/Atorvastatin分类
医药卫生引用本文复制引用
郝建光..早期强化阿托伐他汀治疗不稳定型心绞痛患者45例临床观察[J].中国医药科学,2014,(11):69-70,107,3.
